Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03739775
NA

Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses (CIRCA-HPV)

Sponsor: Institut Curie

View on ClinicalTrials.gov

Summary

ctDNA detection in patients with previously treated, HPV-induced, stage II or III invasive pelvic cancer and who are currently in post-treatment follow-up.

Official title: Circulating Tumor DNA for the Early Detection of HPV-positive Pelvic Cancer Relapses

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

172

Start Date

2019-01-24

Completion Date

2026-06-19

Last Updated

2026-07-07

Healthy Volunteers

No

Interventions

PROCEDURE

Blood sampling

Patients will have a blood draw at each visit to the hospital and at least 6 months (+/- 1 month) intervals.

Locations (5)

CHU de Besançon

Besançon, France

Institut Curie - Paris

Paris, France

Hôpital Tenon

Paris, France

CHU Pontchaillou

Rennes, France

Institut Curie - Saint-Cloud

Saint-Cloud, France